Thanks for your summary. I am interested to watch the recording when it is made available. The following, IMO, will be key to generating interest here (along with finally getting more clinical data): "CYP's keen interest in out- licensing the technology to larger partners early in the clinical/commercial pathways to generate early revenues"
Ann: Investor Webinar Presentation, page-4
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.025(7.46%) |
Mkt cap ! $55.68M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 31.0¢ | $69.62K | 219.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37054 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 36751 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
31.5¢ |
Change
-0.025 ( 5.32 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 33.5¢ | 31.0¢ | 58449 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CYP (ASX) Chart |